CoChat

Longevity in Untreated Congenital Growth Hormone Deficiency Due to a Homozygous Mutation in the GHRH Receptor Gene

Open access
Aguiar-Oliveira, Manuel H., Oliveira, Francielle T., Pereira, Rossana M. C., Oliveira, Carla R. P., Blackford, Amanda, Valenca, Eugenia H. O., Santos, Elenilde G., Gois-Junior, Miburge B., Meneguz-Moreno, Rafael A., Araujo, Vanessa P., Oliveira-Neto, Luis A., Almeida, Roque P., Santos, Mário A., Farias, Natalia T., Silveira, Debora C. R., Cabral, Gabriel W., Calazans, Flavia R., Seabra, Juliane D., Lopes, Tiago F., Rodrigues, Endrigo O., Porto, Livia A., Oliveira, Igor P., Melo, Enaldo V., Martari, Marco, Salvatori, Roberto · 2010 · The Journal of Clinical Endocrinology & Metabolism

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

CONTEXT: Reduced longevity observed in hypopituitarism has been attributed to GH deficiency (GHD). It is, however, unclear whether GHD or other confounding factors cause this early mortality. OBJECTIVE: The aim was to study longevity in subjects from a large kindred with untreated, lifetime isolated GHD (IGHD) due to a homozygous mutation in the GHRH receptor gene and in heterozygous carriers of the mutation. DESIGN, SETTING, AND PARTICIPANTS: We carried out a retrospective cohort study on three groups. We first compared mortality risk of 65 IGHD individuals and their 128 unaffected siblings from 34 families. We then compared mean age of death of the IGHD to the general population. A transversal study was carried out to compare the rate of heterozygosity for the mutation in two groups of young (20-40 yr old) and old (60-80 yr old) normal-appearing subjects from the same county. MAIN OUTCOME MEASURE: We measured longevity. RESULTS: The risk of death of IGHD subjects was not different from their siblings. Life span in IGHD individuals was shorter than the general population. When stratified by sex, this difference persisted only in females, due to a high frequency of IGHD deaths in females aged 4-20. There was no significant difference in life span between IGHD subjects and siblings or the general population when analyzing subjects who reached age 20. The prevalence of heterozygosity did not differ in young and old groups, suggesting no survival advantage or disadvantage. CONCLUSIONS: In a selected genetic background, lifelong untreated IGHD does not affect longevity.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2009-1879

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 44 · Cited by 118

Metadata

Authors
Aguiar-Oliveira, M. H., Oliveira, F. T., Pereira, R. M. C., Oliveira, C. R. P., Blackford, A., Valenca, E. H. O., Santos, E. G., Gois-Junior, M. B., Meneguz-Moreno, R. A., Araujo, V. P., Oliveira-Neto, L. A., Almeida, R. P., Santos, M. A., Farias, N. T., Silveira, D. C. R., Cabral, G. W., Calazans, F. R., Seabra, J. D., Lopes, T. F., Rodrigues, E. O., Porto, L. A., Oliveira, I. P., Melo, E. V., Martari, M., & Salvatori, R.
Affiliations
  • Department of Medicine (M.H.A.-O., F.T.O., R.M.C.P., C.R.P.O., E.H.O.V., E.G.S., M.B.G.-J., R.A.M.-M., V.P.A., L.A.O.-N., R.P.A., M.A.S., N.T.F., D.C.R.S., G.W.C., F.R.C., J.D.S., T.F.L., E.O.R., L.A.P., I.P.O., E.V.M.), Federal University of Sergipe, Aracaju, Sergipe, Brazil 49060-100
  • Johns Hopkins University (US)
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2010-02-01
Volume
95
Issue
2
Pages
714-721
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2033724835
Cited by
118
References
44
Citations by year
2026: 4 · 2025: 3 · 2024: 7 · 2023: 7 · 2022: 10 · 2021: 7 · 2020: 6 · 2019: 6 · 2018: 7 · 2017: 7 · 2016: 14 · 2015: 6 · 2014: 6 · 2013: 7 · 2012: 7
FWCI
4.85
Type
journal article
Language
en
Open access
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5r01dk065718-04)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK065718, R01 DK065718)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
isolated growth hormone deficiency, congenital growth hormone deficiency, GHRH receptor mutation, homozygous mutation, heterozygous carriers, longevity, mortality risk, hypopituitarism, familial kindred, sex differences in mortality
MeSH terms
Adult, Aged, Aged, 80 and over, Female, Heterozygote, Homozygote, Humans, Longevity, Male, Middle Aged, Mutation, Retrospective Studies, Cohort Studies, Receptors, Neuropeptide, Receptors, Pituitary Hormone-Regulating Hormone, Human Growth Hormone

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Longevity in Untreated Congenital Growth Hormone Deficiency Due to a Homozygous Mutation in the GHRH Receptor Gene. https://app.cochat.ai/papers/10.1210/jc.2009-1879
The paper
Aguiar-Oliveira, M. H., Oliveira, F. T., Pereira, R. M. C., Oliveira, C. R. P., Blackford, A., Valenca, E. H. O., Santos, E. G., Gois-Junior, M. B., Meneguz-Moreno, R. A., Araujo, V. P., Oliveira-Neto, L. A., Almeida, R. P., Santos, M. A., Farias, N. T., Silveira, D. C. R., Cabral, G. W., Calazans, F. R., Seabra, J. D., Lopes, T. F., . . . Salvatori, R. (2010). Longevity in Untreated Congenital Growth Hormone Deficiency Due to a Homozygous Mutation in the GHRH Receptor Gene. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2009-1879

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.